Investor Presentation Q1-3 2013

SEMPERIT GROUP INVESTOR PRESENTATION Q1-3 2013 12 November 2013

1

Key Highlights Q1-3 2013: Strong performance, weak environment

Investor Presentation I 12 November 2013 I Investor Relations 2

Revenue up by 11.2% to EUR 684.4m in Q1-3 2013 EBITDA +23.9% to EUR 102.0m, EBIT +19.6% to EUR 69.0m Active raw material management and lower input factor costs supported

earnings growth Strong performance in both sectors driven by high flexibility in capacity

and costs and increase in market shares – despite weak economy

On-going growth and higher profitability Revenue by segments Q3 2013 (vs. Q3 2012)

Sempermed 48% (45%)

Semperform 15% (15%)

Semper- trans 17% (17%)

Semperflex 20% (23%)

Europe 63% (59%)

Asia, Africa, RoW 16% (15%)

North & South America 21% (26%)

Lower raw material prices compared to Q1-3 2012 Bottoming out and slight increase in raw material prices since mid 2013

Medical Sector Unchanged growth of the gloves market (non-cyclical trend) Price pressure continued due to competition and excess supply Industrial Sector Relevant customer industries (energy, construction, engineering)

continue to be influenced by weak economy Semperit gained market shares and achieved excellent profitability

Bottoming out of raw material prices

Economic impact on Semperit Group

Revenue by regions Q3 2013 (vs. Q3 2012)

Medical Sector Q1-3 2013: Growth in all regions based on Latexx Partners and strong sales


Long-term average market growth of 5-7% p.a.

Nitrile gloves market grew faster than natural latex gloves market

Continued pricing pressure due to excess capacity

Successful integration of Latexx Partners within one year

Examination gloves with double-digit sales growth based on expanded business in medical as well as non-medical areas and Latexx Partners

Satisfactory demand for surgical gloves in core markets

Overall capacity utilisation in Sempermed above 80%

Market

Business development

Integration of Latexx Partners

Completion of the integration in Q4 2013

Semperit holds a stake of 98% (fully diluted, as of 30.09.2013)

Industrial Sector Q1-3 2013: Positive development despite economic headwind


Solid performance in a difficult economic environment

Hydraulic Hoses: strong business and market share increase in Europe

Industrial Hoses: new products and market entry in Asia and the USA

Excellent development with volume and revenue growth

>EUR 100m contract with German RWE as largest single order in history

Capacities fully utilised beyond year end 2013

Semperflex

Sempertrans

Significant volume growth in almost all business units

Expanded sales in Building Profiles and Industrial Moulded Parts

Handrails with increased sales and better efficiency in China and expanded ASM market shares in the USA and Europe

Semperform

5

Financial Performance

Q1-3 2013: Best nine-month-results in company history


1) Including Corporate Center: costs of EUR 13.0 m in Q1-3 2013 (EUR 8.9m in Q1-3 2012) 2) Earnings per share attributable to shareholders of Semperit AG Holding

Q1-3 2013

Q1-3 2012 %

331.0 278.8 +18.7%

44.1 31.2 +41.6%

13.3% 11.2% +2.1 pp

27.8 22.0 +26.3%

8.4% 7.9% +0.5 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (per reporting date)

Medical Sector Industrial Sector

Q1-3 2013

Q1-3 2012 %

353.4 336.7 +5.0%

70.7 59.8 +18.1%

20.0% 17.8% +2.2 pp

54.2 44.5 +21.7%

15.3% 13.2% +2.1 pp

Q1-3 2013

Q1-3 2012 %

684.4 615.5 +11.2%

102.0 82.3 +23.9%

14.9% 13.4% +1.5 pp

69.0 57.7 +19.6%

10.1% 9.4% +0.7 pp

44.5 35.4 +25.7%

2.15 1.72 +24.8%

31.4 29.6 +5.8%

9,926 8,113 +22.3%

Group Total1)

Q3 2013: Highlights of a strong quarter


1) Including Corporate Center: costs of EUR 5.4m in Q3 2013 (EUR 2.6m in Q3 2012) 2) Earnings per share attributable to shareholders of Semperit AG Holding

Q3 2013 Q3 2012 %

112.7 96.6 +16.6%

15.9 12.7 +25.2%

14.1% 13.2% +0.9 pp

10.7 9.7 +9.4%

9.5% 10.1% -0.6 pp

in EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR2)

CAPEX

Employees (per reporting date)

Medical Sector Industrial Sector

Q3 2013 Q3 2012 %

120.3 109.1 +10.3

25.5 18.2 +39.9%

21.2% 16.7% +5.0 pp

19.9 13.0 +52.4%

16.5% 12.0% +4.5 pp

Q3 2013 Q3 2012 %

233.0 205.8 +13.2%

36.3 28.4 +27.6%

15.6% 13.8% +1.8 pp

25.3 20.2 +25.2%

10.8% 9.8% +1.0 pp

16.2 11.5 40.9%

0.79 0.56 +40.2%

11.5 12.9 -11.1%

9,926 8,113 +22.3%

Group Total1)

Medical Sector: On-going growth in competitive markets


in EUR m Q1-3 2013 Q1-3 2012 %

Revenue 331.0 278.8 +18.7%

EBITDA 44.1 31.2 +41.6%

EBITDA margin 13.3% 11.2% +2.1 pp

Depreciation -16.4 -9.2 +78.0%

EBIT 27.8 22.0 +26.3%

EBIT margin 8.4% 7.9% +0.5 pp

Q1-3 2013: continued uptrend

Revenue growth of 18.7% to EUR 331.0m

Higher sales volumes were partly offset by negative price effects

Successful Latexx Partners integration with positive impact on earnings and margins

EBIT impacted by substantially higher depreciation

Key Financials Sempermed

Q3 2013 Q3 2012 %

112.7 96.6 +16.6%

15.9 12.7 +25.2%

14.1% 13.2% +0.9 pp

-5.3 -3.0 +77.1%

10.7 9.7 +9.4%

9.5% 10.1% -0.6 pp

Industrial Sector: High profitability based on flexibility and raw material management


Semperflex

Sempertrans

Semperform

Almost stable revenue despite weak market environment

High profitability based on flexible capacity and cost management

Excellent EBITDA margin of 22.9% (Q1-3 2012: 22.0%)

Revenue growth of 11.5% due to volume increase

Profitability benefited from active raw material procurement

EBITDA margin increased to 15.7% vs. 11.5% in Q1-3 2012

Revenue and profit growth despite economic headwind

Volume increases were partly offset by negative price effects

EBITDA margin improved to 21.0% vs. 18.5% in Q1-3 2012

in EUR m Q1-3 2013

Q1-3 2012 % Q3

2013 Q3

2012 %

Revenue 137.5 139.6 -1.5% 47.0 43.6 +8.0%

EBIT 22.7 22.7 +0.4% 7.8 5.8 +38.1%

EBIT margin 16.5% 16.3% +0.3 pp 16.7% 13.3% +3.7 pp

Excellent double-digit margins despite weak economy

in EUR m Q1-3 2013

Q1-3 2012 % Q3

2013 Q3

2012 %

Revenue 115.6 103.7 +11.5% 37.2 32.4 +14.7%

EBIT 15.0 8.6 +73.7% 5.2 2.6 +97.2

EBIT margin 13.0% 8.3% +4.7 pp 14.0% 8.1% +5.9 pp

in EUR m Q1-3 2013

Q1-3 2012 % Q3

2013 Q3

2012 %

Revenue 100.4 93.4 +7.4% 36.1 33.1 +8.9%

EBIT 16.5 13.2 +26.3% 6.8 4.6 +49.5%

EBIT margin 16.5% 14.1% +2.4 pp 18.9% 14.0% +5.2 pp

Strong cash flow, rising net liquidity, very solid balance sheet


1) excl. non-controlling interests 2) Q1-3 2012 adjusted, see notes of interim report

in EUR m Q1-3 2013 Q1-3 20122) % Q3 2013 Cash flow from operating activities 100.5 69.6 +44.2% 47.9

Cash flow from investment activities -49.5 -22.1 +124.0% -14.4

Cash flow from financing activities -10.8 -18.5 -41.3% 27.0

Equity ratio at 50%

Rising net liquidity

Increased Cash flow from operating activities

in EUR m 30.9.2013 31.12.2012 % 30.6.2013 Cash and cash equivalents 169.5 133.3 +27.2% 111.9

Corporate Schuld-schein Loan and Bank liabilities

138.4 118.5 +16.8% 107.7

Net liquidity 31.1 14.8 +110.1% 4.2

in EUR m 30.9.2013 31.12.2012 % 30.6.2013

Total assets 836.7 824.5 +1.5% 815.2

Equity1) 414.1 406.2 +1.9% 411.2

Equity ratio 49.5% 49.3% +0.2pp 50.4%

Outlook


Development of Semperit Group

Unchanged targets

Group: Current level of incoming orders expected to continue beyond 2013, almost fully utilised capacities

Medical Sector: Completion of Latexx Partners integration, on-going market growth but unchanged price pressure

Industrial Sector: Relatively stable demand in all segments in the next months expected

CAPEX: Close to EUR 50m in 2013, includes initial Sempertrans investments in Poland

No economic rebound anticipated in general

Increasing raw material prices expected

Average double digit growth from 2010-2015 (CAGR) EBITDA margin of 12 - 15% EBIT margin of 8 - 11 %

Market view

Contact and Financial calendar


Investor Relations [email protected] +43 1 79777 - 210 www.semperitgroup.com/en/ir Modecenterstrasse 22 1031 Vienna, Austria

Financial calendar 2014 of Semperit 27 March 2014 Publication of FY 2013 and press conference 29 April 2014 Annual general meeting, Vienna 6 May 2014 Ex-dividend day 8 May 2014 Dividend payment day 20 May 2014 Report on Q1 2014 19 August 2014 Report on H1 2014 18 November 2014 Report on Q1-3 2014

Disclaimer The information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes.

We have prepared this presentation and verified the information contained in it with the greatest possible care. In spite of this, rounding, typesetting and printing errors cannot be ruled out. Rounding of differences in the totalling of rounded amounts and percentages may arise from the automatic processing of data.

The forecasts, plans and forward-looking statements contained in this presentation are based on the knowledge and information available and the assessments made at the time that this presentation was prepared (editorial deadline: 8 November 2013). As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements.

APPENDIX

13

Financial Overview

Debt maturity profile

Revenue & earnings development


Positive EBITDA-margin, also in years of financial crisis Due to the financial crisis there was a decrease in revenues

from 2008 to 2009 by approx. 10% Steady revenue increase since 2009

Credit facility in place in Austria (EUR 180m facility, maturity in 2015), no utilisation as of October 31, 2013

Small local credit facilities in place in two subsidiaries, rolled over regularly

Corporate Schuldschein loan issued in July 2013 (EUR 125m): tranches with five, seven and ten years maturity placed mainly in Europe and partly in Asia proceeds used to refinance acquisition of Latexx

Partners, Malaysia in 2012 and to implement the on-going growth programme of the Semperit Group

13.4% 17.5% 16.3% 13.4% 13.1%

0

20

40

60

80

100

120

0

150

300

450

600

750

900

2008 2009 2010 2011 2012

in EURmin EURm

Revenue (LHS) EBITDA margin (%) EBITDA (RHS)

0

10

20

30

40

50

60

70

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

in EURm Maturity Schuldschein Debt

Solid long-term earnings development

Sound debt maturity profile